Although a compromised epidermal permeability barrier can contribute to the development of contact dermatitis, whether subjects with hand eczema display abnormalities in baseline epidermal permeability barrier function in their uninvolved skin remains unknown. The aim of the present study was to assess epidermal permeability barrier function in subjects with and without hand eczema in clothing manufacturers. Upon approval by the institutional review board, volunteers were recruited from clothing manufacturers in Guangzhou City, China. An 11-item questionnaire was used to collect general data from the volunteers. The diagnoses of self-proclaimed hand eczema were further confirmed by a dermatologist. Epidermal biophysical properties, including transepidermal water loss (TEWL) rates, stratum corneum hydration and skin surface pH were measured on the flexural surface of the left forearm in all volunteers. Epidermal biophysical properties were compared among cohorts of subjects with active hand eczema, a prior history of hand eczema and without any history of hand eczema. A total of 650 questionnaires were collected from 462 females and 188 males, with a mean age of 36.7 ± 0.46 years (range 16–69 years; 95% CI 35.8–37.59). Thirty-five subjects (5.4%) currently had hand eczema, while 28 subjects (4.3%) reported a prior history of hand eczema that was inactive currently. The prevalence of hand eczema did not differ significantly between genders. Neither a prior personal nor a family history of allergies was associated with the prevalence of hand eczema, but certain occupations and frequent contact with disinfectants were independently associated with the prevalence of hand eczema. In the overall cohort, males displayed higher TEWL rates and stratum corneum hydration levels than did females. Both skin surface pH and TEWL rates differed significantly among normal controls and subjects with active hand eczema or a prior history of hand eczema (p < 0.05). In conclusion, the uninvolved skin site of subjects with hand eczema exhibits abnormalities in epidermal perme-ability barrier, supporting a pathogenic role of epidermal dysfunction in hand eczema. Whether subjects with hand eczema in other occupations also display altered epidermal function on uninvolved skin remains to be explored.

1.
Elias
PM
,
Wood
LC
,
Feingold
KR
.
Epidermal pathogenesis of inflammatory dermatoses
.
Am J Contact Dermat
.
1999
Sep
;
10
(
3
):
119
26
.
[PubMed]
1046-199X
2.
Chamlin
SL
,
Kao
J
,
Frieden
IJ
,
Sheu
MY
,
Fowler
AJ
,
Fluhr
JW
, et al.
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity
.
J Am Acad Dermatol
.
2002
Aug
;
47
(
2
):
198
208
.
[PubMed]
0190-9622
3.
Liu
M
,
Li
X
,
Chen
XY
,
Xue
F
,
Zheng
J
.
Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial
.
Dermatol Ther (Heidelb)
.
2015
Nov-Dec
;
28
(
6
):
373
82
.
[PubMed]
2193-8210
4.
Man
MQ
,
Ye
L
,
Hu
L
,
Jeong
S
,
Elias
PM
,
Lv
C
.
Improvements in epidermal function prevent relapse of psoriasis: a self-controlled study
.
Clin Exp Dermatol
.
2019
Aug
;
44
(
6
):
654
7
.
[PubMed]
0307-6938
5.
Hu
L
,
Mauro
TM
,
Dang
E
,
Man
G
,
Zhang
J
,
Lee
D
, et al.
Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines
.
J Invest Dermatol
.
2017
Jun
;
137
(
6
):
1277
85
.
[PubMed]
0022-202X
6.
Scharschmidt
TC
,
Man
MQ
,
Hatano
Y
,
Crumrine
D
,
Gunathilake
R
,
Sundberg
JP
,et al.
Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol.
2009
;124:496-506, 506.e1-6.
7.
de Jongh
CM
,
Khrenova
L
,
Verberk
MM
,
Calkoen
F
,
van Dijk
FJ
,
Voss
H
, et al.
Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study
.
Br J Dermatol
.
2008
Sep
;
159
(
3
):
621
7
.
[PubMed]
0007-0963
8.
Molin
S
,
Vollmer
S
,
Weiss
EH
,
Ruzicka
T
,
Prinz
JC
.
Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis
.
Br J Dermatol
.
2009
Oct
;
161
(
4
):
801
7
.
[PubMed]
0007-0963
9.
Molin
S
,
Merl
J
,
Dietrich
KA
,
Regauer
M
,
Flaig
M
,
Letulé
V
, et al.
The hand eczema proteome: imbalance of epidermal barrier proteins
.
Br J Dermatol
.
2015
Apr
;
172
(
4
):
994
1001
.
[PubMed]
0007-0963
10.
Denecker
G
,
Hoste
E
,
Gilbert
B
,
Hochepied
T
,
Ovaere
P
,
Lippens
S
, et al.
Caspase-14 protects against epidermal UVB photodamage and water loss
.
Nat Cell Biol
.
2007
Jun
;
9
(
6
):
666
74
.
[PubMed]
1465-7392
11.
Wang
B
,
Liu
LL
,
Zhao
ZT
,
Tu
P
.
Impaired Skin Barrier Function and Downregulated Expression of Caspase-14 in Moderate to Severe Chronic Hand Eczema
.
Dermatology
.
2018
;
234
(
5-6
):
180
5
.
[PubMed]
1018-8665
12.
Molin
S
,
Vollmer
S
,
Weiss
EH
,
Weisenseel
P
,
Ruzicka
T
,
Prinz
JC
.
Deletion of the late cornified envelope genes LCE3B and LCE3C may promote chronic hand eczema with allergic contact dermatitis
.
J Investig Allergol Clin Immunol
.
2011
;
21
(
6
):
472
9
.
[PubMed]
1018-9068
13.
Ye
L
,
Wang
Z
,
Li
Z
,
Lv
C
,
Man
MQ
.
Validation of GPSkin Barrier® for assessing epidermal permeability barrier function and stratum corneum hydration in humans
.
Skin Res Technol
.
2019
Jan
;
25
(
1
):
25
9
.
[PubMed]
0909-752X
14.
Behroozy
A
,
Keegel
TG
.
Wet-work Exposure: A Main Risk Factor for Occupational Hand Dermatitis
.
Saf Health Work
.
2014
Dec
;
5
(
4
):
175
80
.
[PubMed]
2093-7911
15.
Johannisson
A
,
Pontén
A
,
Svensson
Å
.
Prevalence, incidence and predictive factors for hand eczema in young adults - a follow-up study
.
BMC Dermatol
.
2013
Oct
;
13
(
1
):
14
.
[PubMed]
1471-5945
16.
Darlenski
R
,
Kazandjieva
J
,
Tsankov
N
,
Fluhr
JW
.
Acute irritant threshold correlates with barrier function, skin hydration and contact hypersensitivity in atopic dermatitis and rosacea
.
Exp Dermatol
.
2013
Nov
;
22
(
11
):
752
3
.
[PubMed]
0906-6705
17.
Mehta
HH
,
Nikam
VV
,
Jaiswal
CR
,
Mehta
HB
.
A cross-sectional study of variations in the biophysical parameters of skin among healthy volunteers
.
Indian J Dermatol Venereol Leprol
.
2018
Jul-Aug
;
84
(
4
):
521
.
[PubMed]
0378-6323
18.
Mekonnen
TH
,
Yenealem
DG
,
Tolosa
BM
.
Self-report occupational-related contact dermatitis: prevalence and risk factors among healthcare workers in Gondar town, Northwest Ethiopia, 2018-a cross-sectional study
.
Environ Health Prev Med
.
2019
Feb
;
24
(
1
):
11
.
[PubMed]
1342-078X
19.
Hamnerius
N
,
Svedman
C
,
Bergendorff
O
,
Björk
J
,
Bruze
M
,
Pontén
A
.
Wet work exposure and hand eczema among healthcare workers: a cross-sectional study
.
Br J Dermatol
.
2018
Feb
;
178
(
2
):
452
61
.
[PubMed]
0007-0963
20.
Coenraads
PJ
.
Hand eczema
.
N Engl J Med
.
2012
Nov
;
367
(
19
):
1829
37
.
[PubMed]
0028-4793
21.
Coenraads
PJ
,
Diepgen
TL
.
Risk for hand eczema in employees with past or present atopic dermatitis
.
Int Arch Occup Environ Health
.
1998
Feb
;
71
(
1
):
7
13
.
[PubMed]
0340-0131
22.
Nutten
S
.
Atopic dermatitis: global epidemiology and risk factors
.
Ann Nutr Metab
.
2015
;
66
Suppl 1
:
8
16
.
[PubMed]
0250-6807
23.
Yucesoy
B
,
Talzhanov
Y
,
Michael Barmada
M
,
Johnson
VJ
,
Kashon
ML
,
Baron
E
, et al.
Association of MHC region SNPs with irritant susceptibility in healthcare workers
.
J Immunotoxicol
.
2016
Sep
;
13
(
5
):
738
44
.
[PubMed]
1547-691X
24.
Lodén
M
,
Wirén
K
,
Smerud
K
,
Meland
N
,
Hønnås
H
,
Mørk
G
, et al.
Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study
.
Acta Derm Venereol
.
2010
Nov
;
90
(
6
):
602
6
.
[PubMed]
0001-5555
25.
Jordan
L
.
Efficacy of a Hand Regimen in Skin Barrier Protection in Individuals With Occupational Irritant Contact Dermatitis
.
J Drugs Dermatol
.
2016
Nov
;
15
(
11
):
s81
5
.
[PubMed]
1545-9616
26.
Ruff
SM
,
Engebretsen
KA
,
Zachariae
C
,
Johansen
JD
,
Silverberg
JI
,
Egeberg
A
, et al.
The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis
.
Br J Dermatol
.
2018
Apr
;
178
(
4
):
879
88
.
[PubMed]
0007-0963
27.
Handa
S
,
Khullar
G
,
Pal
A
,
Kamboj
P
,
De
D
.
Filaggrin gene mutations in hand eczema patients in the Indian subcontinent: A prospective case-control study
.
Contact Dermat
.
2019
Jun
;
80
(
6
):
359
64
.
[PubMed]
0105-1873
28.
Landeck
L
,
Visser
M
,
Kezic
S
,
John
SM
.
Genotype-phenotype associations in filaggrin loss-of-function mutation carriers
.
Contact Dermat
.
2013
Mar
;
68
(
3
):
149
55
.
[PubMed]
0105-1873
29.
Lerbaek
A
,
Bisgaard
H
,
Agner
T
,
Ohm Kyvik
K
,
Palmer
CN
,
Menné
T
.
Filaggrin null alleles are not associated with hand eczema or contact allergy
.
Br J Dermatol
.
2007
Dec
;
157
(
6
):
1199
204
.
[PubMed]
0007-0963
30.
Lerbaek
A
,
Kyvik
KO
,
Mortensen
J
,
Bryld
LE
,
Menné
T
,
Agner
T
.
Heritability of hand eczema is not explained by comorbidity with atopic dermatitis
.
J Invest Dermatol
.
2007
Jul
;
127
(
7
):
1632
40
.
[PubMed]
0022-202X
31.
Angelova-Fischer
I
,
Mannheimer
AC
,
Hinder
A
,
Ruether
A
,
Franke
A
,
Neubert
RH
, et al.
Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling
.
Exp Dermatol
.
2011
Apr
;
20
(
4
):
351
6
.
[PubMed]
0906-6705
32.
Jungersted
JM
,
Scheer
H
,
Mempel
M
,
Baurecht
H
,
Cifuentes
L
,
Høgh
JK
, et al.
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema
.
Allergy
.
2010
Jul
;
65
(
7
):
911
8
.
[PubMed]
0105-4538
33.
Wood
LC
,
Elias
PM
,
Calhoun
C
,
Tsai
JC
,
Grunfeld
C
,
Feingold
KR
.
Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis
.
J Invest Dermatol
.
1996
Mar
;
106
(
3
):
397
403
.
[PubMed]
0022-202X
34.
Nishijima
T
,
Tokura
Y
,
Imokawa
G
,
Seo
N
,
Furukawa
F
,
Takigawa
M
.
Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption
.
J Invest Dermatol
.
1997
Aug
;
109
(
2
):
175
82
.
[PubMed]
0022-202X
35.
Gupta
J
,
Grube
E
,
Ericksen
MB
,
Stevenson
MD
,
Lucky
AW
,
Sheth
AP
, et al.
Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity
.
J Allergy Clin Immunol
.
2008
Mar
;
121
(
3
):
725
730.e2
.
[PubMed]
0091-6749
36.
Kim
DW
,
Park
JY
,
Na
GY
,
Lee
SJ
,
Lee
WJ
.
Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis
.
Int J Dermatol
.
2006
Jun
;
45
(
6
):
698
701
.
[PubMed]
0011-9059
37.
Sugarman
JL
,
Fluhr
JW
,
Fowler
AJ
,
Bruckner
T
,
Diepgen
TL
,
Williams
ML
.
The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease
.
Arch Dermatol
.
2003
Nov
;
139
(
11
):
1417
22
.
[PubMed]
0003-987X
38.
Darlenski
R
,
Hristakieva
E
,
Aydin
U
,
Gancheva
D
,
Gancheva
T
,
Zheleva
A
, et al.
Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis
.
J Dermatol Sci
.
2018
Jul
;
91
(
1
):
28
34
.
[PubMed]
0923-1811
39.
Horimukai
K
,
Morita
K
,
Narita
M
,
Kondo
M
,
Kabashima
S
,
Inoue
E
, et al.
Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations
.
Allergol Int
.
2016
Jan
;
65
(
1
):
103
8
.
[PubMed]
1323-8930
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.